31.07.2017
Merck and Acino signed a distribution agreement
Acino will commercialize present 9 Merck products for the treatment of cardiovascular and endocrine diseases in Ukraine, Armenia, Azerbaijan, Kazakhstan,...
Acino will commercialize present 9 Merck products for the treatment of cardiovascular and endocrine diseases in Ukraine, Armenia, Azerbaijan, Kazakhstan,...
Acino has acquired South Africa’s Litha Healthcare. Litha, headquartered in Johannesburg, provides services and products to public and private hospitals,...
Acino signed a deal with certain subsidiaries of Endo International plc to acquire Litha Healthcare in South Africa. Litha Healthcare,...
Acino announces the appointment of Mario Ricard as Chief Operations Officer and member of the Executive Committee effective February 15,...
Barthold Piening, Chief Operations Officer and Member of the Executive Committee, has decided to leave Acino by mid of this...
On November 30, 2016, Acino International AG and Acino Pharma AG (together “Acino”) closed the deal with Luye Pharma Group...
Following the announcement of Acino and Takeda that Acino will acquire Takeda’s manufacturing site in Põlva, Estonia, the closing of...
Acino is very pleased to launch today its new corporate brand identity and its new website under the URL www.acino.swiss.The new...
Today Acino International AG and Acino Pharma AG (together “Acino”) have signed a definitive agreement with Luye Pharma Group Ltd....